James’ only concerning symptom leading up to his diagnosis was bilateral edema. But, after a stroke, James spent a month in the hospital and received a surprising diagnosis of Wild-Type Transthyretin Amyloidosis. James shares his story and optimism just months after his diagnosis.
Patient Resources
Wild-type ATTR: James’ story
Related Content
-
ATTR Clinical Trial UpdatesWebinars
-
ATTR Cardiac TreatmentsWebinars
-
ARC Research Roundtable ReportPublications
Get the latest Amyloidosis news and research from ARC.
Join our newsletter